A detailed history of Calamos Advisors LLC transactions in Inotiv, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 66,431 shares of NOTV stock, worth $292,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,431
Holding current value
$292,296
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$1.68 - $5.95 $111,604 - $395,264
66,431 New
66,431 $275,000
Q2 2022

Aug 01, 2022

SELL
$9.56 - $25.91 $771,664 - $2.09 Million
-80,718 Reduced 84.26%
15,082 $145,000
Q1 2022

May 03, 2022

SELL
$18.52 - $40.41 $1.45 Million - $3.16 Million
-78,230 Reduced 44.95%
95,800 $2.51 Million
Q4 2021

Feb 01, 2022

BUY
$30.55 - $57.88 $983,404 - $1.86 Million
32,190 Added 22.69%
174,030 $7.32 Million
Q3 2021

Oct 26, 2021

BUY
$23.69 - $49.93 $1.68 Million - $3.55 Million
71,042 Added 100.34%
141,840 $4.15 Million
Q2 2021

Jul 22, 2021

BUY
$18.9 - $31.42 $1.34 Million - $2.22 Million
70,798 New
70,798 $1.89 Million

Others Institutions Holding NOTV

About Inotiv, Inc.


  • Ticker NOTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 25,594,500
  • Market Cap $113M
  • Description
  • Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...
More about NOTV
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.